Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 4:07 AM
Ignite Modification Date:
2025-12-25 @ 4:07 AM
NCT ID:
NCT00828620
Eligibility Criteria:
Inclusion Criteria:
* Histologically or cytologically proven colorectal cancer
* Unresectable stage IV disease
* K-Ras wild type tumour
* Patients scheduled to undergo chemotherapy with irinotecan and cetuximab
Exclusion Criteria:
* Prior abdominal/pelvic radiotherapy, surgery or chemotherapy within 3 months prior to inclusion in the study
* Poorly controlled diabetes
* Concomitant serious illness, such as uncontrolled angina pectoris, myocardial infarction, heart failure, uncontrolled hypertension, infection
* Symptomatic brain metastases
* Pregnancy or participants of reproductive potential who are sexually active and not willing/able to use medically appropriate contraception
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Study:
NCT00828620
Study Brief:
Protocol Section:
NCT00828620